These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9554469)

  • 1. Short stature caused by a natural growth hormone antagonist.
    Chihara K; Takahashi Y; Kaji H; Goji K; Okimura Y; Abe H
    Horm Res; 1998; 49 Suppl 1():41-5. PubMed ID: 9554469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short stature caused by a mutant growth hormone with an antagonistic effect.
    Takahashi Y; Kaji H; Okimura Y; Goji K; Abe H; Chihara K
    Endocr J; 1996 Oct; 43 Suppl():S27-32. PubMed ID: 9076339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity.
    Petkovic V; Thevis M; Lochmatter D; Besson A; Eblé A; Flück CE; Mullis PE
    Eur J Endocrinol; 2007 Aug; 157 Suppl 1():S67-74. PubMed ID: 17785701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature.
    Petkovic V; Besson A; Thevis M; Lochmatter D; Eblé A; Flück CE; Mullis PE
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2893-901. PubMed ID: 17519310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM; Julius JR; Stoppani C; Rundle AC
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short stature by mutant growth hormones.
    Takahashi Y; Chihara K
    Growth Horm IGF Res; 1999 Jun; 9 Suppl B():37-40; discussion 40-1. PubMed ID: 10549304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and molecular mechanisms of bioinactive growth hormone (review).
    Takahashi Y; Chihara K
    Int J Mol Med; 1998 Sep; 2(3):287-91. PubMed ID: 9855700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short stature and low IGF-1 and IGFBP-3 despite normal growth hormone secretion in a 4 year-old girl with primary empty sella syndrome.
    Dötsch J; Blum WF; Rascher W; Kreuder J; Kiess W
    J Pediatr Endocrinol Metab; 1996; 9(3):415-8. PubMed ID: 8887152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically inactive growth hormone caused by an amino acid substitution.
    Takahashi Y; Shirono H; Arisaka O; Takahashi K; Yagi T; Koga J; Kaji H; Okimura Y; Abe H; Tanaka T; Chihara K
    J Clin Invest; 1997 Sep; 100(5):1159-65. PubMed ID: 9276733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of idiopathic growth hormone deficiency: contributions of data on the acid-labile subunit, insulin-like growth factor (IGF)-I and-II, and IGF binding protein-3.
    Trivin C; Souberbielle JC; Aubertin G; Lawson-Body E; Adan L; Brauner R
    J Pediatr Endocrinol Metab; 2006 Apr; 19(4):481-9. PubMed ID: 16759033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
    Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.
    Iida K; Takahashi Y; Kaji H; Nose O; Okimura Y; Abe H; Chihara K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):531-7. PubMed ID: 9467570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.